FP05.03 Multiomic, Plasma-Only ctDNA NGS Assay Developed for Minimal Residual Disease (MRD) Detection in Early-Stage NSCLC

Autor: Kurata, J., Price, K., Banks, K., Zotenko, E., Dinman, T., Parsana, P., Miao, Z., Ju, J., Hite, D., Cheng, D., Talasaz, A.
Zdroj: In Journal of Thoracic Oncology October 2021 16(10) Supplement:S952-S953
Databáze: ScienceDirect